{"log_id": 546951959067693815, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0, "average": 0.999786, "min": 0.999786}, "location": {"width": 21, "top": 166, "height": 57, "left": 1167}, "words": "品"}, {"probability": {"variance": 0.001212, "average": 0.985404, "min": 0.848819}, "location": {"width": 363, "top": 226, "height": 25, "left": 257}, "words": "如阿米替林、 SSRIS和锂盐)合用时的风险"}, {"probability": {"variance": 0.00774, "average": 0.957655, "min": 0.726728}, "location": {"width": 140, "top": 271, "height": 24, "left": 237}, "words": "5-羟色胺综合征"}, {"probability": {"variance": 0.00602, "average": 0.976099, "min": 0.617753}, "location": {"width": 734, "top": 316, "height": 26, "left": 282}, "words": "类似其它5羟色胺能药物,使用文拉法辛治疗时可能发生5-羟色胺综合征(有潜在生命"}, {"probability": {"variance": 0.006113, "average": 0.981196, "min": 0.5031}, "location": {"width": 761, "top": 362, "height": 26, "left": 236}, "words": "威胁),尤其是在与以下药物合并使用时:其它作用于5-羟色胺递质系统的药物(包括曲坦"}, {"probability": {"variance": 0.010788, "average": 0.961497, "min": 0.592699}, "location": {"width": 774, "top": 407, "height": 26, "left": 241}, "words": " SSRIS、其它 SNRIS、锂盐、西布曲明、曲马多或圣约翰草[金丝桃属植物提取物],损害5"}, {"probability": {"variance": 0.000532, "average": 0.989047, "min": 0.900723}, "location": {"width": 718, "top": 452, "height": 27, "left": 237}, "words": "羟色胺代谢的药物(如 MAOIS,包括利奈唑胺【一种抗生素,是可逆性、非选择性的M"}, {"probability": {"variance": 0.004994, "average": 0.974376, "min": 0.603125}, "location": {"width": 575, "top": 499, "height": 24, "left": 241}, "words": "或5-羟色胺前体(如:色氨酸补充剂)(见【禁忌】和【注意事项】"}, {"probability": {"variance": 0.007723, "average": 0.973291, "min": 0.509028}, "location": {"width": 733, "top": 542, "height": 25, "left": 284}, "words": "如果临床上必须要合用交拉法辛和某种 SSRI. SNRI或5-羟色胺受体激动剂(曲坦),建"}, {"probability": {"variance": 0.000765, "average": 0.990819, "min": 0.847065}, "location": {"width": 781, "top": 585, "height": 28, "left": 236}, "words": "议密切监测患者,尤其在治疗初期和增加剂量时。不推荐合并使用文拉法辛和5羟色胺前体"}, {"probability": {"variance": 3.5e-05, "average": 0.996833, "min": 0.982333}, "location": {"width": 233, "top": 632, "height": 25, "left": 237}, "words": "物质(如:色氨酸补充剂)"}, {"probability": {"variance": 0.005056, "average": 0.981418, "min": 0.568721}, "location": {"width": 736, "top": 675, "height": 27, "left": 283}, "words": "曲坦:上市后报道罕见合并使用SSRI和曲坦引起的5羟色胺综合征。如果临床上需要"}, {"probability": {"variance": 2e-05, "average": 0.998266, "min": 0.973955}, "location": {"width": 636, "top": 721, "height": 26, "left": 238}, "words": "同时使用本品和曲坦,建议密切监测患者,尤其在治疗初期和增加剂量时"}, {"probability": {"variance": 0.000105, "average": 0.994528, "min": 0.974038}, "location": {"width": 100, "top": 768, "height": 24, "left": 242}, "words": "电抽搐治疗"}, {"probability": {"variance": 0.000241, "average": 0.995232, "min": 0.924868}, "location": {"width": 436, "top": 810, "height": 27, "left": 285}, "words": "目前尚无临床资料提示本品合并电抽搐治疗的益处"}, {"probability": {"variance": 3e-06, "average": 0.997952, "min": 0.99497}, "location": {"width": 112, "top": 856, "height": 24, "left": 244}, "words": "【药物过量】"}, {"probability": {"variance": 1e-06, "average": 0.999416, "min": 0.99803}, "location": {"width": 85, "top": 900, "height": 25, "left": 284}, "words": "人类经验"}, {"probability": {"variance": 0.000718, "average": 0.99353, "min": 0.840813}, "location": {"width": 734, "top": 942, "height": 29, "left": 286}, "words": "在上市前以盐酸文拉法辛缓释胶囊治疗抑郁症的研究中,单独服用本品或与其他药物"}, {"probability": {"variance": 0.005058, "average": 0.973152, "min": 0.667486}, "location": {"width": 777, "top": 988, "height": 26, "left": 241}, "words": "合用,有2例受试者发生急性药物过量,其中1例患者服用6g盐酸文拉法辛缓释胶囊和2.5mg"}, {"probability": {"variance": 0.00097, "average": 0.987796, "min": 0.858689}, "location": {"width": 750, "top": 1028, "height": 32, "left": 241}, "words": "劳拉西泮,该患者入院,给予对症治疗后康复且无其他不良反应;另外一名患者2"}, {"probability": {"variance": 3.5e-05, "average": 0.996791, "min": 0.979569}, "location": {"width": 455, "top": 1075, "height": 29, "left": 241}, "words": "本品,该患者报告了四肢感觉异常,恢复后无后遗症"}, {"probability": {"variance": 0.000516, "average": 0.989986, "min": 0.890326}, "location": {"width": 579, "top": 1118, "height": 28, "left": 286}, "words": "在盐酸文拉法辛缓释胶囊的GAD试验中,有2例急性药物过量事件发"}, {"probability": {"variance": 0.068087, "average": 0.810782, "min": 0.441802}, "location": {"width": 60, "top": 1122, "height": 23, "left": 957}, "words": "例患者"}, {"probability": {"variance": 0.010944, "average": 0.9676, "min": 0.396976}, "location": {"width": 757, "top": 1164, "height": 27, "left": 241}, "words": "同时服用0.75g盐酸文拉法辛缓释胶囊、200mg帕罗西汀和50mg唑坦,该患者意识清醒"}, {"probability": {"variance": 8.6e-05, "average": 0.996422, "min": 0.951938}, "location": {"width": 777, "top": 1206, "height": 31, "left": 243}, "words": "可以交谈、轻度嗜睡,被收住入院,使用活性碳治疗后康复无其他不良反应外例患者"}, {"probability": {"variance": 0.004831, "average": 0.982936, "min": 0.548728}, "location": {"width": 776, "top": 1253, "height": 29, "left": 242}, "words": "服用1.2g盐酸文拉法辛缓释胶囊,该患者康复并无发现特殊异常。该患者服药过量后5天内"}, {"probability": {"variance": 0.000272, "average": 0.994092, "min": 0.903325}, "location": {"width": 668, "top": 1299, "height": 26, "left": 242}, "words": "出现了中度眩晕、嗜睡、四肢麻木以及时冷时热,此类症状一周后可自行消失"}, {"probability": {"variance": 0.000384, "average": 0.994243, "min": 0.891797}, "location": {"width": 733, "top": 1342, "height": 28, "left": 286}, "words": "盐酸文拉法辛缓释胶囊治疗抑郁症的研究中无急性药物过量事件报道。在本品治疗恐"}, {"probability": {"variance": 0.000156, "average": 0.994903, "min": 0.950631}, "location": {"width": 370, "top": 1388, "height": 28, "left": 242}, "words": "慌症研究中,有2例急性药物过量事件发生"}, {"probability": {"variance": 0.000686, "average": 0.985324, "min": 0.910548}, "location": {"width": 371, "top": 1388, "height": 24, "left": 648}, "words": "便患者一次服用0.675g盐酸文拉法辛缓释胶"}, {"probability": {"variance": 9.4e-05, "average": 0.996229, "min": 0.944148}, "location": {"width": 777, "top": 1430, "height": 30, "left": 242}, "words": "囊,另外一例患者2日内服用了0.45g本品,两者均未发生药物过量的体征和症状,并未采取"}, {"probability": {"variance": 1e-06, "average": 0.999195, "min": 0.997085}, "location": {"width": 83, "top": 1480, "height": 24, "left": 242}, "words": "治疗措施"}, {"probability": {"variance": 0.002482, "average": 0.988396, "min": 0.687103}, "location": {"width": 734, "top": 1520, "height": 28, "left": 285}, "words": "盐酸文拉法辛胶囊(速释)的上市前评估中,有14例文拉法辛急性药物过量事件发生"}], "language": 3}